The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Wei-Ting Chang1, Chih Hsien Lin2, Chon-Seng Hong2

  • 1Department of Cardiology, Chi Mei Medical Center, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.

Journal of Cardiology
|November 25, 2020
PubMed

Insights

Left ventricular global longitudinal strain (LV GLS) predicts changes in ejection fraction (EF) and cardiovascular death risk in heart failure with mid-range EF (HFmrEF). Impaired LV GLS indicates a higher risk of worsening EF and mortality in HFmrEF patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Heart failure with mid-range ejection fraction (HFmrEF) encompasses patients with left ventricular ejection fraction (LVEF) between 41-49%.
  • Prognostic indicators and the natural progression of LV function in HFmrEF remain incompletely understood.
  • The utility of LV global longitudinal strain (LV GLS) in predicting outcomes for HFmrEF patients requires further investigation.

Purpose of the Study:

  • To assess if LV GLS can differentiate changes in LVEF over time.
  • To determine the predictive value of LV GLS for clinical outcomes in HFmrEF.
  • To identify potential prognostic markers for HFmrEF.

Main Methods:

  • 273 HFmrEF outpatients were categorized based on LVEF changes during follow-up: HF with worse EF (HFwEF), HF with similar EF (HFsEF), and HF with recovered EF (HFrecEF).
  • Baseline LV GLS was measured using echocardiography.
  • Patient outcomes, including hospitalization for HF and cardiovascular death, were monitored over an average of 31 months.

Main Results:

  • A more impaired baseline LV GLS was associated with a higher likelihood of developing HFwEF.
  • Patients achieving HFrecEF demonstrated a reduced risk of HF hospitalization compared to those in HFwEF and HFsEF groups.
  • LV GLS at a cutoff of -11% effectively predicted cardiovascular death risk, with values >-11% indicating high risk.

Conclusions:

  • LV GLS is a valuable marker for predicting LVEF trajectory and cardiovascular mortality in HFmrEF.
  • Achieving recovered EF (HFrecEF) is linked to a lower risk of HF hospitalization.
  • LV GLS measurement can aid in risk stratification and management strategies for HFmrEF patients.
Abstract